<DOC>
	<DOCNO>NCT01062932</DOCNO>
	<brief_summary>Psychosocial treatment drug abuse benefit patient ( Rawson et al 2004 ) , urgent need new treatment approach improve treatment outcome . One new approach involve facilitation extinction condition response use d-cycloserine , partial agonist NMDA glycine site . This approach prove useful treatment several anxiety disorder . For example , treatment d-cycloserine enhance efficacy behavioral treatment acrophobia ( Ressler et al 2004 ) social phobia ( Hofmann et al 2006 ) enhance extinction condition fear response . This suggest d-cycloserine potential enhance efficacy behavioral treatment drug dependence enhance extinction condition response drug cue . In Phase I Cutting-Edge Basic Research Awards ( CEBRA ) application propose proof-of-concept study examine effect treatment d-cycloserine facilitating extinction crave provoked exposure cigarette smoking cue . The benefit treatment approach together cognitive behavioral treatment reduce cigarette smoking determine . Smoking cue present use establish virtual reality simulator ( Bordnick et al 2004 ; Bordnick et al 2005a )</brief_summary>
	<brief_title>Investigation Cycloserine Smoking Cessation Treatment</brief_title>
	<detailed_description>See brief summary</detailed_description>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Want participate treatment aim help stop smoking cigarette Be Englishspeaking volunteer 1855 year age Meet DSMIV TR criterion current nicotine dependence smoke &gt; 10 cigarette per day past year Meet DSMIV TR criterion cocaine dependence , seek treatment cocaine dependence time study Have medical history brief physical examination demonstrate clinically significant contraindication study participation , judgment admit physician principal investigator Meet DSMIV TR criterion abuse dependence alcohol drug , except nicotine cocaine Have psychiatric disorder , : current major depression assess SCID ; lifetime history schizophrenia , psychotic illness , bipolar illness assess SCID ; current organic brain disease dementia assess clinical interview ; history current psychiatric disorder would require ongoing treatment would make study compliance difficult ; history seizure disorder severe head injury Have evidence untreated unstable medical illness include : neuroendocrine , autoimmune , renal , hepatic , active infectious disease Be pregnant nursing . Female participant must either unable conceive ( i.e. , surgically sterilize , sterile , postmenopausal ) use reliable form contraception ( e.g. , abstinence , birth control pill , intrauterine device , condom , spermicide ) . All female must provide negative pregnancy urine test study entry end study participation Have history adverse response dcycloserine Have illness , condition , use medication , opinion P.I . and/or admit physician would preclude safe and/or successful completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Cycloserine</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Smoking</keyword>
</DOC>